UnknownPhase 4NCT05306223
A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China
Studying Tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Beijing Chest Hospital
- Principal Investigator
- Mengqiu GaoBeijing Chest Hospital
- Intervention
- Bedaquiline(drug)
- Enrollment
- 212 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2022 – 2025
Study locations (17)
- Beijing Chest Hospital, Beijing, China
- The Eighth Medical Center of PLA General Hospital, Beijing, China
- Changsha Central Hospital, Changsha, China
- Public health clinical medical center of Chengdu, Chengdu, China
- Chongqing Public Health Medical Center, Chongqing, China
- The Pulmonary Hospital of Fuzhou in Fujian Province（The tuberculosis control and prevention Hospital of Fuzhou in Fujian Province）, Fuzhou, China
- Guiyang Public Health Clinical Center, Guiyang, China
- Anhui Chest Hospital, Hefei, China
- Infectious Disease Hospital of Heilongjiang Province, Heilongjiang, China
- Jiamusi Tumor Hospital, Jiamusi, China
- Jiangxi Chest Hospital, Jiangxi, China
- Shandong public health clinical center, Shandong, China
- Shanghai Pulmonary Hospital, Shanghai, China
- Shenyang Chest Hospital, Shenyang, China
- Wuhan Pulmonary Hospital, Wuhan, China
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05306223 on ClinicalTrials.govOther trials for Tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07164742Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)Johns Hopkins University
- RECRUITINGNCT0707721318F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis PatientsChildren's Hospital Medical Center, Cincinnati
- RECRUITINGNCT07451899TB Type and Spirometry Result vs. Functional Capacity Based on 6MWT in People With Post-TB Lung DiseaseUniversitas Padjadjaran
- RECRUITINGNCT06845618Blood Tuberculosis DNA Levels to Monitor Tuberculosis TreatmentUniversity of Oxford
- ENROLLING BY INVITATIONNANCT06984887Evaluation of New TB Diagnostic Tests (NATs) in PakistanMercy Corps Pakistan
- RECRUITINGNCT07018076Candidate Clinical Correlate of Prognostic Outcome for TB StudyUniversity of California, San Francisco
- RECRUITINGNANCT07271225Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and VomitingIndonesia University
- RECRUITINGNCT06585358DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary TuberculosisKarolinska Institutet